Ignite Creation Date:
2024-05-06 @ 8:11 AM
Last Modification Date:
2024-10-26 @ 11:57 AM
Study NCT ID:
NCT02680379
Status:
COMPLETED
Last Update Posted:
2018-10-15
First Post:
2016-01-25
Brief Title:
Combined Treatment of Minocycline and Lovastatin to Treat Individuals With Fragile X Syndrome
Sponsor:
Université de Sherbrooke
Organization:
Université de Sherbrooke
Study Overview
Official Title:
A Pilot Study Exploring the Safety and Synergistic Effect of a MinocyclineLovastatin Combined Treatment on the Behavior of Individuals With Fragile X Syndrome Validation of New Biochemical and Neurophysiological Markers LovaMiX
Status:
COMPLETED
Status Verified Date:
2018-10
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
LovaMiX
Brief Summary:
The purpose of this study is to determine whether Lovastatin Minocycline and the combination LovastatinMinocycline are effective in treating behavioral symptoms in Fragile X individuals
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None